gamma-Aminobutyric acid
- Generic Name
- gamma-Aminobutyric acid
- Drug Type
- Small Molecule
- Chemical Formula
- C4H9NO2
- CAS Number
- 56-12-2
- Unique Ingredient Identifier
- 2ACZ6IPC6I
- Background
The most common inhibitory neurotransmitter in the central nervous system.
- Associated Conditions
- Brain Health
GABA and Beta-cell Regeneration
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Ministry of Health and Population, Egypt
- Target Recruit Count
- 100
- Registration Number
- NCT04375020
- Locations
- 🇪🇬
Mahmoud Younis, Cairo, Egypt
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- Sherief Abd-Elsalam
- Target Recruit Count
- 30
- Registration Number
- NCT04144439
- Locations
- 🇪🇬
Sherief Abd-Elsalam, Tanta, Egypt
Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology
Phase 4
Completed
- Conditions
- Agitation States as Acute Reaction to Exceptional StressVomitingPain, PostoperativeAnesthesia
- Interventions
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2018-09-27
- Lead Sponsor
- Hospital Infantil Albert Sabin
- Target Recruit Count
- 135
- Registration Number
- NCT03681574
- Locations
- 🇧🇷
Hospital Infantil Albert Sabin, Fortaleza, Ceara, Brazil
Assessment of Peripheral GABA Receptors for Local Pain Relief
Not Applicable
- Conditions
- Pain
- Interventions
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- Aalborg University
- Target Recruit Count
- 90
- Registration Number
- NCT02928328
- Locations
- 🇩🇰
Aalborg University, Aalborg, Denmark
The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
Phase 1
Completed
- Conditions
- Type I Diabetes
- Interventions
- Drug: Placebo GABA and Placebo GAD-alumDrug: Active Oral GABA and Active GAD-alum injection
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 101
- Registration Number
- NCT02002130
- Locations
- 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States
How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units
Phase 1
Terminated
- Conditions
- DeliriumRespiratory Failure
- Interventions
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT00826553
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 78
- Registration Number
- NCT00218166
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath